Subscribe to RSS
DOI: 10.1055/s-2007-970770
Deracemization of Acyclic α-Hydroxy Ketone Derivatives by Dynamic Resolution Using an Optically Active Host Compound
Publication History
Publication Date:
08 March 2007 (online)
![](https://www.thieme-connect.de/media/synlett/200705/lookinside/thumbnails/10.1055-s-2007-970770-1.jpg)
Abstract
The dynamic resolution of racemic acyclic α-hydroxy ketone derivatives is accomplished using an optically active host compound, TADDOL, under basic conditions to give the corresponding optically active ketones.
Key words
acyclic ketones - deracemization - enantiomeric resolution - host-guest systems - optically active compounds
- Recent reviews for asymmetric protonation:
-
1a
Eames J.Suggate MJ. Angew. Chem. Int. Ed. 2005, 44: 186 -
1b
Duhamel L.Duhamel P.Plaquevent J.-C. Tetrahedron: Asymmetry 2004, 15: 3653 - Recent examples for asymmetric protonation:
-
2a
Mitsuhashi K.Ito R.Arai T.Yanagisawa A. Org. Lett. 2006, 8: 1721 -
2b
Nakashima D.Yamamoto H. Synlett 2006, 150 -
2c
Reynods NT.Rovis T. J. Am. Chem. Soc. 2005, 127: 16406 -
2d
Coumbarides GS.Eames J.Scheuermann JEW.Sibbons KF.Suggate MJ.Watkinson M. Bull. Chem. Soc. Jpn. 2005, 78: 906 -
2e
Gil J.Medio-Simon M.Mancha G.Asensio G. Eur. J. Org. Chem. 2005, 1561 -
2f
Melgar-Fernandez R.Juaristi E. Tetrahedron Lett. 2005, 46: 1221 -
3a
Ohta H.Matsumoto K.Tsutsumi S.Ihori T. J. Chem. Soc., Chem. Commun. 1989, 485 -
3b
Matsumoto K.Ohta H. Chem. Lett. 1989, 1589 -
3c
Matsumoto K.Tsutsumi S.Ihori T.Ohta H. J. Am. Chem. Soc. 1990, 112: 9614 -
3d
Matsumoto K.Oishi T.Nakata T.Shibata T.Ohta K. Biocatalysis 1994, 9: 97 -
3e
Matsumoto K.Kitajima H.Nakata T. J. Mol. Catal. B: Enzym. 1995, 1: 17 - 4
Matsumoto K.Ohta H. Tetrahedron Lett. 1991, 32: 4729 - Recent reviews for enzymatic deracemization:
-
5a
Fotheringham I.Archer I.Carr R.Speight R.Turner NJ. Biochem. Soc. Trans. 2006, 34: 287 -
5b
Strauss UT.Felfer U.Faber K. Tetrahedron: Asymmetry 1999, 10: 107 -
5c
Kroutil W.Faber K. Tetrahedron: Asymmetry 1998, 9: 2901 -
6a
Larissegger B.Kroutil W.Faber K. Synlett 2005, 1936 -
6b
Carr R.Alexeeva M.Dawson MJ.Gotor-Fernandez V.Humphrey CE.Cara E.Turner NJ. ChemBioChem 2005, 6: 637 -
6c
Cardus GJ.Carnell AJ.Trauthwein H.Riemeir T. Tetrahedron: Asymmetry 2004, 15: 239 -
6d
Beard TM.Turner NJ. Chem. Commun. 2002, 246 -
7a
Baskar B.Pandian NG.Priya K.Chadha A. Tetrahedron 2005, 61: 12296 -
7b
Mitsukura K.Yoshida T.Nagasawa T. Biotechnol. Lett. 2002, 24: 1615 -
7c
Rhys-Williams W.Thomason MJ.Hung Y.-F.Hanlon GW.Lloyd AW. Chirality 1998, 10: 528 -
7d
Reichel C.Brugger R.Bang H.Geisslinger G.Brune K. Mol. Pharmacol. 1997, 51: 576 -
7e
Rhys-Williams W.Thomason MJ.Lloyd AW.Hanlon GW. Pharm. Sci. 1996, 2: 537 -
7f
Menzel S.Waibel R.Brune K.Geisslinger G. Biochem. Pharmocol. 1994, 48: 1056 -
8a
Kato D.-I.Miyamoto K.Ohta H. Biocatal. Biotransform. 2005, 23: 375 -
8b
Kato D.-I.Miyamoto K.Ohta H. Tetrahedron: Asymmetry 2004, 15: 2965 -
8c
Kato D.-I.Satoshi M.Ohta H. J. Org. Chem. 2003, 68: 7234 -
8d
Kato D.-I.Satoshi M.Ohta H. Org. Lett. 2002, 4: 371 - 9
Pirkle WH.Reno DS. J. Am. Chem. Soc. 1987, 109: 7189 -
10a
Toda F.Mori K. J. Chem. Soc., Chem. Commun. 1986, 1357 -
10b
Brussee J.Groenendijk JLG.te Koppele JM.Jansen ACA. Tetrahedron 1985, 41: 3313 -
10c
Toda F.Tanaka K. Chem. Lett. 1983, 12: 661 -
11a
Kaku H.Okamoto N.Nakamura A.Tsunoda T. Chem. Lett. 2004, 33: 516 -
11b
Kaku H.Takaoka S.Tsunoda T. Tetrahedron 2002, 58: 3401 -
11c
Kaku H.Ozako S.Kawamura S.Takatsu S.Ishii M.Tsunoda T. Heterocycles 2001, 55: 847 -
11d
Tsunoda T.Kaku H.Nagaku M.Okuyama E. Tetrahedron Lett. 1997, 38: 7759 - 13
Matsumoto K.Okamoto T.Otsuka K. Bull. Chem. Soc. Jpn. 2004, 77: 2051 - 21
Matsumoto K.Suzuki N.Ohta H. Tetrahedron Lett. 1990, 31: 7159
References and Notes
The substrate (±)-1 was easily prepared from (±)-lactic acid in four steps. The details of this synthesis have been reported in ref. 13.
14The absolute configuration of 1 was confirmed by comparing the obtained optical rotation value with the reported value: Lit. [21] [α]D 24 -45.9 (c 1.16, CHCl3), S-form.
15The ee of 1 was determined by HPLC analysis with CHIRALCEL OJ (Daicel Chemical Industries, Ltd.); eluent, hexane-2-PrOH = 180:1; flow rate, 0.5 mL min-1; t R = 40 (R) and 50 (S) min.
16The deracemization did not occur for the reactions using the other TADDOL derivatives bearing a cyclopentane ring and a dimethyl group [(-)-2,2-tetramethylene- and 2,2-dimethyl-α,α,α′,α′-tetraphenyl-1,3-dioxolan-4,5-dimethanol, respectively], (+)-1,1′-bi-2-naphthol, and (-)-hydrobenzoin as chiral host compounds under the same conditions.
17Although the ee of (S)-1 increased according to the extension of the reaction time (42% ee for one day), the reaction for over three days gave almost the same result as that of the three-day reaction. We then decided that the racemizations in all cases were carried out for three days.
18The reaction using EtOH, i-PrOH, t-BuOH, and cyclohexane as an alternative mix solvent with H2O gave only the racemate 1.
19A white solid was obtained by filtration when a sat. NH4Cl aq and EtOAc were not added to the reaction mixture. ESI-TOFMS analysis of the collected solid showed the peak of [1 + 2 + Na]+ ion (m/z = 721.3 for C46H50O6Na) in the same manner as the case of the optical resolution. [13] The peak would mean the construction of the 1:1 inclusion complex (1 and 2) in the reaction mixture.
20The ee of the products can be improved by a sequential optical resolution using (-)-2 without a base. [13]